Duality Advisers’s Agilon Health AGL Stock Holding History

Duality Advisers’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-611	Closed	-$192K	–	582
2023 Q4	$192K	Buy	+611	New	+$221K	0.02%	551

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Duality Advisers's AGL Position: Q1 2024 in Review

Duality Advisers sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 611 shares — an estimated $192K sold.

Duality Advisers first reported a position in AGL in Q4 2023 and held it in 1 quarter. The position peaked at $192K in Q4 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

Duality Advisers reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
Duality Advisers sold 611 Agilon Health shares in Q1 2024, an estimated $192K.
Duality Advisers first reported a position in Agilon Health in Q4 2023 and held it in 1 quarter.
Duality Advisers's Agilon Health position peaked at $192K in Q4 2023.
198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Duality Advisers's 13F filing for Q1 2024, filed 6 May 2024.